Related Experiment Video
Updated: Jun 13, 2025
Detection of Small GTPase Prenylation and GTP Binding Using Membrane Fractionation and GTPase-linked Immunosorbent Assay
Published on: November 11, 2018
Quantifying small GTPase activation status using a novel fluorescence HPLC-based assay
Makoto Araki1, Yukika Kasuya1, Kaho Yoshimoto1
1Department of Biochemistry, Meiji Pharmaceutical University, Tokyo, Japan.
Abstract:
Small GTPases play crucial roles in cellular signaling pathways, with their activation states tightly regulated between GDP-bound inactive and GTP-bound active forms. Dysregulation of these nucleotide-binding states, such as in oncogenic RAS, is implicated in diseases like cancer. Accurately quantifying these states in cells is thus crucial for deciphering their functional roles and regulatory mechanisms. However, current methods do not fully meet the necessary sensitivity and versatility, limiting their effectiveness in small GTPase analysis. Here, we present a highly sensitive HPLC-based assay with fluorescence detection (Fluor-HPLC), enabling precise quantification of guanine nucleotide-binding states in small GTPases. Applying this technique, we successfully quantified the guanine nucleotide-binding states of small GTPases at their endogenous expression levels. We demonstrated the utility of Fluor-HPLC by elucidating RHEB and HRAS activation in response to extracellular stimuli. Furthermore, integration of Fluor-HPLC with syngeneic mouse models provided insights into KRAS activation dynamics in tumor tissues and evaluated the effectiveness of targeted therapeutics. Overall, this versatile method paves the way for investigating activation states and regulatory mechanisms of various small GTPases, potentially accelerating our understanding of their roles in cellular processes and disease pathogenesis.
Insights
A new Fluor-HPLC assay precisely quantifies small GTPase activation states, crucial for understanding cancer and cellular signaling. This method advances research into GTPase function and disease pathogenesis.
Area of Science:
- Biochemistry
- Cell Biology
- Molecular Biology
Background:
- Small GTPases are key regulators of cellular signaling pathways.
- Their activation states (GDP-bound inactive vs. GTP-bound active) are critical for function.
- Dysregulation of GTPase states, like in RAS oncogenes, contributes to diseases such as cancer.
Purpose of the Study:
- To develop a highly sensitive and versatile method for quantifying small GTPase activation states.
- To overcome limitations of existing techniques in small GTPase analysis.
- To enable precise measurement of GTPase nucleotide-binding states in cellular and in vivo models.
Main Methods:
- Development of a highly sensitive High-Performance Liquid Chromatography (HPLC)-based assay with fluorescence detection (Fluor-HPLC).
- Quantification of guanine nucleotide-binding states of small GTPases at endogenous expression levels.
- Application of Fluor-HPLC in cellular studies and syngeneic mouse models.
Main Results:
- Fluor-HPLC successfully quantified small GTPase guanine nucleotide-binding states with high sensitivity.
- The method elucidated RHEB and HRAS activation in response to extracellular stimuli.
- KRAS activation dynamics in tumor tissues were investigated, and therapeutic efficacy was evaluated in mouse models.
Conclusions:
- Fluor-HPLC is a versatile and sensitive method for precise quantification of small GTPase activation states.
- This technique facilitates the study of GTPase roles in cellular processes and disease.
- The method has potential to accelerate understanding of GTPase-related pathogenesis and therapeutic strategies.
